Trials / Completed
CompletedNCT05013164
Role of Folinic Acid in Improving the Adaptive Skills and Language Impairment in Children With Autism Spectrum Disorder
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Nishtar Medical University · Academic / Other
- Sex
- All
- Age
- 3 Years – 14 Years
- Healthy volunteers
- Accepted
Summary
No such study has been conducted in Pakistan so the primary objective of this study was to determine the role of folinic acid in improving the speech and adaptive skills while secondary objective was improvement of stereotype movements and hyperactivity in ASD among children aged 3 to 14 years.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Folinic Acid | Folinic Acid was given at the dose of 2mg/kg per day in two divide doses( maximum 50 mg per day) given for 12 weeks |
Timeline
- Start date
- 2020-10-01
- Primary completion
- 2021-03-30
- Completion
- 2021-03-30
- First posted
- 2021-08-19
- Last updated
- 2021-08-24
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT05013164. Inclusion in this directory is not an endorsement.